BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 17071030)

  • 1. Effects of drying technique on extrusion-spheronisation granules and tablet properties.
    Song B; Rough SL; Wilson DI
    Int J Pharm; 2007 Mar; 332(1-2):38-44. PubMed ID: 17071030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol and MCC-dicalcium phosphate-Carbopol pellets.
    Gómez-Carracedo A; Souto C; Marti Nez-Pacheco R; Concheiro A; Gómez-Amoza JL
    Eur J Pharm Biopharm; 2008 Jun; 69(2):675-85. PubMed ID: 18248805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of drying methods on the physicochemical and compressional characteristics of Okra powder and the release properties of its metronidazole tablet formulation.
    Bakre LG; Jaiyeoba KT
    Arch Pharm Res; 2009 Feb; 32(2):259-67. PubMed ID: 19280157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of non-contact laser profilometry to the determination of permanent structural change induced by compaction of pellets II. Pellets dried by different techniques.
    Bashaiwoldu AB; Podczeck F; Newton JM
    Eur J Pharm Sci; 2004 May; 22(1):55-61. PubMed ID: 15113583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roller compaction of different pseudopolymorphic forms of theophylline: Effect on compressibility and tablet properties.
    Hadzović E; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
    Int J Pharm; 2010 Aug; 396(1-2):53-62. PubMed ID: 20600735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insensitivity of compaction properties of brittle granules to size enlargement by roller compaction.
    Wu SJ; Sun C
    J Pharm Sci; 2007 May; 96(5):1445-50. PubMed ID: 17455348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of shape and porosity on the compression behaviour and tablet forming ability of granular materials formed from microcrystalline cellulose.
    Johansson B; Alderborn G
    Eur J Pharm Biopharm; 2001 Nov; 52(3):347-57. PubMed ID: 11677077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on the effect of drying techniques on the mechanical properties of pellets and compacted pellets.
    Bashaiwoldu AB; Podczeck F; Newton JM
    Eur J Pharm Sci; 2004 Feb; 21(2-3):119-29. PubMed ID: 14757483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The granule porosity controls the loss of compactibility for both dry- and wet-processed cellulose granules but at different rate.
    Nordström J; Alderborn G
    J Pharm Sci; 2015 Jun; 104(6):2029-2039. PubMed ID: 25872760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spray-dried cellulose nanofibers as novel tablet excipient.
    Kolakovic R; Peltonen L; Laaksonen T; Putkisto K; Laukkanen A; Hirvonen J
    AAPS PharmSciTech; 2011 Dec; 12(4):1366-73. PubMed ID: 22005956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of drying on extruded pellets based on kappa-carrageenan.
    Thommes M; Blaschek W; Kleinebudde P
    Eur J Pharm Sci; 2007 Jun; 31(2):112-8. PubMed ID: 17448646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cushioning pellets based on microcrystalline cellulose - Crospovidone blends for MUPS tableting.
    Elsergany RN; Chan LW; Heng PWS
    Int J Pharm; 2020 Aug; 586():119573. PubMed ID: 32599135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a continuous twin screw granulation and drying system during formulation development and process optimization.
    Vercruysse J; Peeters E; Fonteyne M; Cappuyns P; Delaet U; Van Assche I; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2015 Jan; 89():239-47. PubMed ID: 25528462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twin product/process approach for pellet preparation by extrusion/spheronisation. Part I: hydro-textural aspects.
    Galland S; Ruiz T; Delalonde M
    Int J Pharm; 2007 Jun; 337(1-2):239-45. PubMed ID: 17317048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical properties of granulating liquids and their influence on microcrystalline cellulose pellets obtained by extrusion-spheronisation technology.
    Dreu R; Sirca J; Pintye-Hodi K; Burjan T; Planinsek O; Srcic S
    Int J Pharm; 2005 Mar; 291(1-2):99-111. PubMed ID: 15707736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To determine the end point of wet granulation by measuring powder energies and thermal properties.
    Dave RH; Wu SH; Contractor LD
    Drug Dev Ind Pharm; 2012 Apr; 38(4):439-46. PubMed ID: 22188039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-infrared chemical imaging (NIR-CI) as a process monitoring solution for a production line of roll compaction and tableting.
    Khorasani M; Amigo JM; Sun CC; Bertelsen P; Rantanen J
    Eur J Pharm Biopharm; 2015 Jun; 93():293-302. PubMed ID: 25917640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.
    Dukić-Ott A; Thommes M; Remon JP; Kleinebudde P; Vervaet C
    Eur J Pharm Biopharm; 2009 Jan; 71(1):38-46. PubMed ID: 18771727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.